ESMO Symposium on Signalling Pathways in Cancer 2018

Oncology Meeting Resources

23 Mar - 24 Mar 2018, Barcelona, Spain

Signalling Pathways 2018 - square

ESMO Symposium on Signalling Pathways in Cancer, in partnership with the European Association for Cancer Research (EACR), will focus on Cyclin-dependent kinases (CDKs). Presentations and webcasts from the ESMO Symposium on Signalling Pathways in Cancer 2018 are available here to ESMO members.

The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity. Meeting programme | Future ESMO meetings

Video report from Violetta Serra on Understanding the Mecanism of Resistance to CDK4/6 Inhibitors

Most of oestrogen receptor positive metastatic breast cancer patients are receiving CDK4/6 inhibitors, now approved for first-line treatment. Violetta Serra explains that the challenge is now to identify resistance to these drugs in order to establish potential second line treatments.





Format available

https://oncologypro.esmo.org/Meeting-Resour...ways-in-Cancer-2018/Welcome-to-the-Symposium

Date: 23 Mar 2018
Presenter: Josep Tabernero
Resources: Presentation, Webcast
Topic: Pathology/Molecular Biology

https://oncologypro.esmo.org/Meeting-Resour...ation-and-biological-basis-of-CDK-inhibition

Date: 23 Mar 2018
Presenter: Marcos Malumbres
Topic: Pathology/Molecular Biology

https://oncologypro.esmo.org/Meeting-Resour...g-pathways-through-control-of-CDK-activation

Date: 23 Mar 2018
Presenter: Luca Malorni
Resources: Presentation, Webcast
Topic: Pathology/Molecular Biology

https://oncologypro.esmo.org/Meeting-Resour...2018/The-biology-of-the-CDK4-CDK6-RB-pathway

Date: 23 Mar 2018
Presenter: Tobias Otto
Resources: Presentation, Webcast
Topic: Pathology/Molecular Biology

https://oncologypro.esmo.org/Meeting-Resour...2-as-the-bypass-kinase-for-CDK4-6-inhibition

Date: 23 Mar 2018
Presenter: Nicholas Turner
Topics: Breast Cancer, Pathology/Molecular Biology

https://oncologypro.esmo.org/Meeting-Resour...g-Pathways-in-Cancer-2018/CDK-4-6-inhibition

Date: 23 Mar 2018
Presenter: Monica Arnedos
Resources: Presentation, Webcast
Topics: Breast Cancer, Pathology/Molecular Biology

https://oncologypro.esmo.org/Meeting-Resour...en-lung-tumors-The-good-the-bad-and-the-ugly

Date: 23 Mar 2018
Presenter: Mariano Barbacid
Resources: Presentation, Webcast
Topic: Pathology/Molecular Biology

https://oncologypro.esmo.org/Meeting-Resour...ancer-2018/DNA-damage-and-checkpoint-kinases

Date: 23 Mar 2018
Presenter: Fabrizio d'Adda di Fagagna
Topic: Pathology/Molecular Biology

https://oncologypro.esmo.org/Meeting-Resour...8/Mechanism-of-resistance-to-CDKs-inhibitors

Date: 23 Mar 2018
Presenter: Giulio Draetta
Topic: Pathology/Molecular Biology

https://oncologypro.esmo.org/Meeting-Resour...clinical-evidence-of-activity-of-abemaciclib

Date: 23 Mar 2018
Presenter: Maria Lallena
Topic: Pathology/Molecular Biology